PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.91%
Revenue growth above 1.5x INTC's 4.52%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-17.38%
Negative gross profit growth while INTC is at 10.81%. Joel Greenblatt would examine cost competitiveness or demand decline.
52.33%
EBIT growth above 1.5x INTC's 15.46%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
52.33%
Operating income growth above 1.5x INTC's 15.46%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
47.70%
Net income growth above 1.5x INTC's 18.22%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
48.39%
EPS growth above 1.5x INTC's 18.18%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
48.39%
Diluted EPS growth above 1.5x INTC's 18.60%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.80%
Share count expansion well above INTC's 0.61%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.80%
Diluted share count expanding well above INTC's 0.53%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-4.93%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.21%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
509.80%
10Y revenue/share CAGR above 1.5x INTC's 56.44%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
55.35%
5Y revenue/share CAGR above 1.5x INTC's 28.80%. David Dodd would look for consistent product or market expansions fueling outperformance.
8.55%
3Y revenue/share CAGR under 50% of INTC's 29.51%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2607.97%
10Y OCF/share CAGR above 1.5x INTC's 33.23%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
526.71%
5Y OCF/share CAGR above 1.5x INTC's 29.55%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
663.79%
3Y OCF/share CAGR above 1.5x INTC's 50.61%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-1062.70%
Negative 10Y net income/share CAGR while INTC is at 11.01%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1976.89%
Negative 5Y net income/share CAGR while INTC is 56.45%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-216.66%
Negative 3Y CAGR while INTC is 135.89%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1568.61%
10Y equity/share CAGR above 1.5x INTC's 50.99%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
87.24%
5Y equity/share CAGR above 1.5x INTC's 34.60%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
30.55%
3Y equity/share CAGR 1.25-1.5x INTC's 20.58%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.63%
AR growth well above INTC's 10.86%. Michael Burry fears inflated revenue or higher default risk in the near future.
-14.68%
Inventory is declining while INTC stands at 12.02%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.77%
Similar asset growth to INTC's 3.44%. Walter Schloss finds parallel expansions or investment rates.
-3.85%
We have a declining book value while INTC shows 6.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.15%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-36.10%
Our R&D shrinks while INTC invests at 6.52%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-37.77%
We cut SG&A while INTC invests at 4.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.